{"article_title": "The Biotech Lobby Fights To Undermine Less-Costly Biosimilar Drugs", "article_keywords": ["biotech", "lesscostly", "drugs", "fights", "biosimilar", "lobby", "undermine"], "article_url": "http://www.forbes.com/sites/theapothecary/2014/09/04/the-biotech-lobby-fights-to-undermine-less-costly-biosimilar-drugs/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "The Apothecary", "og": {"site_name": "Forbes", "description": "By IKE BRANNON: Companies want to make more money for their shareholders, and there\u2019s nothing wrong with that. But an effort to inhibit competition, done in the guise of protecting the consumer when it\u2019s doing nothing of the sort should be recognized by the FDA for what it is.", "title": "The Biotech Lobby Fights To Undermine Less-Costly Biosimilar Drugs", "url": "http://www.forbes.com/sites/theapothecary/2014/09/04/the-biotech-lobby-fights-to-undermine-less-costly-biosimilar-drugs/", "image": "http://img.youtube.com/vi/_rrmpCBdvWs/0.jpg", "updated_time": "2014-09-04T09:25:28-04:00", "type": "article"}, "twitter": {"description": "By IKE BRANNON: Companies want to make more money for their shareholders, and there\u2019s nothing wrong with that. But an effort to inhibit competition, done in the guise of protecting the consumer when it\u2019s doing nothing of the sort should be recognized by the FDA for what it is.", "creator": "@forbesopinion", "image": "http://img.youtube.com/vi/_rrmpCBdvWs/0.jpg", "title": "The Biotech Lobby Fights To Undermine Less-Costly Biosimilar Drugs", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Healthcare  Fiscal,Healthcare &amp; Fiscal", "article": {"publisher": "https://www.facebook.com/forbes", "author": "http://www.facebook.com/https://www.facebook.com/forbesaroy", "section_url": "http://www.forbes.com/healthcare-fiscal", "section": "Healthcare, Fiscal, and Tax", "modified": "2014-09-04", "published": "2014-09-04", "id": "blogAndPostId/blog/post/1314-21438"}, "news_keywords": "Healthcare  Fiscal,Healthcare &amp; Fiscal", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "description": "By IKE BRANNON: Companies want to make more money for their shareholders, and there\u2019s nothing wrong with that. But an effort to inhibit competition, done in the guise of protecting the consumer when it\u2019s doing nothing of the sort should be recognized by the FDA for what it is."}, "_id": "\"57477af36914bd0286fd21c2\"", "article_summary": ""}